Evidence check: SHBG in the context of Blutzucker

SHBG (sex hormone-binding globulin) is frequently discussed in the context of blood sugar and insulin resistance. Epidemiological evidence consistently shows an inverse association: lower SHBG levels correlate with higher risk of type 2 diabetes and impaired glucose tolerance. However, causality remains debated – SHBG may be both a marker and a modulator of insulin metabolism. Genetic variants in the SHBG gene (e.g., rs1799941) have small effects on circulating SHBG but limited clinical utility for predicting individual blood sugar responses. Direct-to-consumer DNA tests reporting SHBG SNPs should be interpreted with caution; lifestyle factors (diet, exercise, body weight) have a much larger impact on both SHBG and glycemic control. Evidence: human-moderate (observational studies, some Mendelian randomization). Caveat: no RCTs confirm that altering SHBG via genetics improves glucose outcomes. No safety concerns.